A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2004
10/20/2004	EP1467801A1 Method of prophylaxis against large myocardial infarctions
10/20/2004	EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS
10/20/2004	EP1467745A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders
10/20/2004	EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
10/20/2004	EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
10/20/2004	EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
10/20/2004	EP1467732A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
10/20/2004	EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
10/20/2004	EP1467730A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
10/20/2004	EP1467726A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
10/20/2004	EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis
10/20/2004	EP1467714A1 Drug mixture with enhanced dissolution rate
10/20/2004	EP1404180A4 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
10/20/2004	EP1368327B1 Benzo thiadiazine matrix metalloproteinase inhibitors
10/20/2004	EP1263725B1 Novel compounds
10/20/2004	EP1246619B1 Urotensin-ii receptor antagonists
10/20/2004	EP1230236B1 Compound with growth hormone releasing properties
10/20/2004	EP1217902B1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
10/20/2004	EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones
10/20/2004	EP1198477B1 Prolactin-releasing peptide and use in treating pain
10/20/2004	EP1181381B1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
10/20/2004	EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/20/2004	EP1171141B1 MEDICAMENT FOR INHIBITING THE NF-kB TRANSCRIPTION FACTOR
10/20/2004	EP1157005B1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
10/20/2004	EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors
10/20/2004	EP1131291B1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
10/20/2004	EP1112253B1 Branched alkyl pyrrolidine-3-carboxylic acids
10/20/2004	EP1073440B1 sPLA 2 INHIBITOR ESTERS
10/20/2004	EP1005351B1 Aqueous metal bicarbonate solutions for the treatment of osteoarthritis
10/20/2004	CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease
10/20/2004	CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins
10/20/2004	CN1538959A Fused-polycyclic compounds
10/20/2004	CN1538956A Spiro compounds
10/20/2004	CN1538955A Pyrrolidine derivatives as factor Xa inhibitors
10/20/2004	CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
10/20/2004	CN1538848A Novel Benzo-fused heterocycles
10/20/2004	CN1538846A Oral administration of 6-hydroxy-oxymorphone for use as antalgesic
10/20/2004	CN1538845A Phenyl derivatives as factor Xa inhibitors
10/20/2004	CN1538844A Novel amides preparation used as modulators of CCR-receptor activity, its preparation and therapeutic use
10/20/2004	CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
10/20/2004	CN1538837A Swallow tablet comprising paracetamol
10/20/2004	CN1538836A Substituted amine derivatives and method of use
10/20/2004	CN1537625A Traditional Chinese medicine tablet prepn. method
10/20/2004	CN1537619A Traditional Chinese medicine for immunity and strengthening the body resistance
10/20/2004	CN1537618A Medicine for treating backache and its prepn. method
10/20/2004	CN1537609A Oral administration medicine for treating exogenous calentura, and its prepn. method
10/20/2004	CN1537595A Zuanshanfeng granule and its prepn. method
10/20/2004	CN1537594A Sugar-free type Zuanshanfeng mixture, and its prepn. method
10/20/2004	CN1537592A Yinqin tablet contg. Chinese medicines, and its prepn. method
10/20/2004	CN1537591A Yinqin Granule contg. Chinese medicines, and its prepn. method
10/20/2004	CN1537587A Sanhuang qingjie granule contg. coptis, phellodendroum and others for cleaning-away heat and detoxifying, and its prepn. method
10/20/2004	CN1537586A Sanhuang Qingjie dispersing tablet contg. coptis, phellodendronum and others for cleaning heat and detoxicating, and its prepn. method
10/20/2004	CN1537580A Honghua Qili tablet contg. safflower carthamus, and its prepn. method
10/20/2004	CN1537579A Qili capsule for treating traumatic injuries, and its prepn. method
10/20/2004	CN1537573A Extraction of active ingredient of Zuanshanfeng, and method for preparing its prepn.
10/20/2004	CN1537572A Qili dispersing tablet for treating traumatic injuries, and its prepn. method
10/20/2004	CN1537571A Strong Rhizoma Gastrodiae and eucommia bark granule, and its prepn. method
10/20/2004	CN1537543A Traditional Chinese medicine for treating high-fever and diarrhoea of AIDS
10/20/2004	CN1537531A Celecoxib compositions
10/20/2004	CN1537491A Golden health-care cushion, and its making method
10/20/2004	CN1171997C Modified TLE-2-receptor ligands
10/20/2004	CN1171902C Antisercretory factor petides regulating pathological permeability changes
10/20/2004	CN1171892C Thienothiazine compound with anti-inflammatory and antalgic activity and its preparing process and usage
10/20/2004	CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
10/20/2004	CN1171888C Substituted purin derivatives, preparation method and use
10/20/2004	CN1171883C Nonsteroidal antiinflammatories
10/20/2004	CN1171872C Compounds for modulation of PPAP gamma activity
10/20/2004	CN1171870C Inhibitors of cysteine protease
10/20/2004	CN1171846C Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
10/20/2004	CN1171625C Ant-shuangshen Tongbi pill for treating rhematoid or rheumatic arthitis and ankylosing spondylitis
10/20/2004	CN1171608C Capsule/medicament for treating rheumtism, rheumatoid archritis and its preparation method
10/20/2004	CN1171607C Medicine for treating periumbilical pain
10/20/2004	CN1171605C Pain-stopping bone-penetrating ointment and its prepn. preocess
10/20/2004	CN1171598C Powder for treating rheumatism or atrophic arthritis
10/19/2004	US6806373 Dissolving leflunomide in a solvent to form a leflunomide solution, crystallizing leflunomide form iii from the leflunomide solution, and isolating leflunomide form iii, useful for the treatment of rheumatoid arthritis
10/19/2004	US6806370 NK-1 receptor active amine oxide prodrugs
10/19/2004	US6806312 Thermoplastic resin composition
10/19/2004	US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects
10/19/2004	US6806282 Branched substituted amino derivatives of 3-amino-1-phenyl-1h-[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
10/19/2004	US6806276 2-oxoquinoline compounds and pharmaceutical uses thereof
10/19/2004	US6806274 Quinazoline derivatives
10/19/2004	US6806273 Compounds
10/19/2004	US6806270 Selective antagonists of A2B adenosine receptors
10/19/2004	US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
10/19/2004	US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent
10/19/2004	US6806251 Method of treating pain
10/19/2004	US6806061 G protein-coupled receptor gene and methods of use therefor
10/19/2004	US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
10/19/2004	CA2308783C Novel derivatives of 1-aza-2-alkyl-6-aryl-cycloalkanes, process for their preparation and pharmaceutical compositions containing them
10/14/2004	WO2004087938A1 Novel physiologically active substances pf1270a, b and c
10/14/2004	WO2004087899A1 Method for obtaining regulating dendritic cells and t cells
10/14/2004	WO2004087763A1 Modified antibody against cd22 and utilization thereof
10/14/2004	WO2004087699A2 Thiazoles useful as inhibitors of protein kinases
10/14/2004	WO2004087698A2 Thiazoles useful as inhibitors of protein kinases
10/14/2004	WO2004087687A1 Chromene derivatives as anti-inflammatory agents
10/14/2004	WO2004087686A2 Benzopyran compounds useful for treating inflammatory conditions
10/14/2004	WO2004087666A1 Novel n-substituted 2-aminopyridine derivatives
10/14/2004	WO2004087665A1 Novel 6-substituted 2-aminopyridine derivatives
10/14/2004	WO2004087646A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
10/14/2004	WO2004087212A2 Nitric oxide in treatment of inflammation

1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 1272